Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Junker

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Arthritis Research & Therapy|April 28, 2017
Increased galectin-3 may serve as a serologic signature of pre-rheumatoid arthritis while markers of synovitis and cartilage do not differ between early undifferentiated arthritis subsetsSaida Farah Issa, Anne Duer, Mikkel Østergaard, et al.
American Journal of Clinical and Experimental Immunology|July 25, 2022
T-cell immunoglobulin and mucin domain 3 is upregulated in rheumatoid arthritis, but insufficient in controlling inflammationCaecilie Skejoe, Aida S Hansen, Kristian Stengaard-Pedersen, et al.
Rheumatology International|January 2, 2021
Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate: secondary analyses from the randomised controlled OPERA trialDženan Mašić, Kristian Stengaard-Pedersen, Brian Bridal Løgstrup, et al.
Rheumatology International|December 2, 2015
Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27Heidi Lausten Munk, Natasja Staehr Gudmann, Anne Friesgaard Christensen, et al.
Arthritis and Rheumatism|September 12, 2013
M-ficolin levels reflect disease activity and predict remission in early rheumatoid arthritisChristian G Ammitzbøll, Steffen Thiel, Jens C Jensenius, et al.
Arthritis Research & Therapy|November 1, 2014
CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patientsChristian Gytz Ammitzbøll, Rudi Steffensen, Martin Bøgsted, et al.
Cancers|September 9, 2023
Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related NeoplasmsHans Carl Hasselbalch, Peter Junker, Vibe Skov, et al.
Frontiers in Immunology|August 5, 2025
Differential DNA methylation patterns in whole blood from ACPA-positive patients with DMARD-naïve rheumatoid arthritis at clinical disease onsetAnders Jørgen Svendsen, Jonas Mengel-From, Peter Junker, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 10, 2017
Soluble CD206 plasma levels in rheumatoid arthritis reflect decrease in disease activityLine Dam Heftdal, Kristian Stengaard-Pedersen, Lykke Midtbøll Ørnbjerg, et al.
Arthritis Research & Therapy|September 25, 2014
CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic 'window of opportunity'Stinne Ravn Greisen, Karen Kræmmer Schelde, Tue Kruse Rasmussen, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Arthritis Research & Therapy|April 28, 2017
Increased galectin-3 may serve as a serologic signature of pre-rheumatoid arthritis while markers of synovitis and cartilage do not differ between early undifferentiated arthritis subsetsSaida Farah Issa, Anne Duer, Mikkel Østergaard, et al.
American Journal of Clinical and Experimental Immunology|July 25, 2022
T-cell immunoglobulin and mucin domain 3 is upregulated in rheumatoid arthritis, but insufficient in controlling inflammationCaecilie Skejoe, Aida S Hansen, Kristian Stengaard-Pedersen, et al.
Rheumatology International|January 2, 2021
Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate: secondary analyses from the randomised controlled OPERA trialDženan Mašić, Kristian Stengaard-Pedersen, Brian Bridal Løgstrup, et al.
Rheumatology International|December 2, 2015
Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27Heidi Lausten Munk, Natasja Staehr Gudmann, Anne Friesgaard Christensen, et al.
Arthritis and Rheumatism|September 12, 2013
M-ficolin levels reflect disease activity and predict remission in early rheumatoid arthritisChristian G Ammitzbøll, Steffen Thiel, Jens C Jensenius, et al.
Arthritis Research & Therapy|November 1, 2014
CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patientsChristian Gytz Ammitzbøll, Rudi Steffensen, Martin Bøgsted, et al.
Cancers|September 9, 2023
Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related NeoplasmsHans Carl Hasselbalch, Peter Junker, Vibe Skov, et al.
Frontiers in Immunology|August 5, 2025
Differential DNA methylation patterns in whole blood from ACPA-positive patients with DMARD-naïve rheumatoid arthritis at clinical disease onsetAnders Jørgen Svendsen, Jonas Mengel-From, Peter Junker, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 10, 2017
Soluble CD206 plasma levels in rheumatoid arthritis reflect decrease in disease activityLine Dam Heftdal, Kristian Stengaard-Pedersen, Lykke Midtbøll Ørnbjerg, et al.
Arthritis Research & Therapy|September 25, 2014
CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic 'window of opportunity'Stinne Ravn Greisen, Karen Kræmmer Schelde, Tue Kruse Rasmussen, et al.
Pageof 8